Speaker

Josep Dalmau, University of Barcelona, IDIBAPS, and ICREA, Spain and University of Pennsylvania, USA

Josep Dalmau

Josep Dalmau received his M.D. and Ph.D. from the Autonoma University of Barcelona, Spain. Dalmau trained in Neuro-oncology at Memorial Sloan-Kettering Cancer Center in New York and afterwards he was appointed to the faculty. After 11 years at Memorial, Dalmau was appointed co-director of Neuro-oncology at the University of Arkansas for Medical Sciences and then Professor of Neurology at the University of Pennsylvania. Dalmau is currently Research Professor at the Catalan Institution for Research and Advanced Studies (ICREA) in The Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)/Hospital Clinic, University of Barcelona, and Adjunct Professor of Neurology at the University of Pennsylvania. Dr. Dalmau’s research is currently focused on autoimmune encephalitis mediated by antibodies to neuronal cell surface and CNS synaptic proteins, a new category of brain disorders that he uncovered and for which he is considered a leading authority. His research is funded by a variety of agencies including the USA National Institutes of Health and the Spanish Ministry of Health. He is the recipient of many awards including the distinguished George W. Jacoby award of the American Neurological Association and the Rey Jaime I Prize, the most prestigious award given in Spain in recognition of his outstanding contributions to clinical medicine and has been elected a member of the National Academy of Medicine, USA. He is a member of many academic societies and serves as Editor-in-Chief of Neurology: Neuroimmunology and Neuroinflammation.

« Go Back

Supporting Publications
Organised by
 
  • Elsevier
  • TLP
  • TLN
Exhibitors
 
  • Encephalitis Society
  • Treating Autism
Sponsors
 
  • Encephalitis Society
  • Treating Autism